mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.7 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
0.027 |
0.7 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |